Form 4 for PHR Phreesia, Inc.
Accepted 2022-01-07 00:00:00 ET · period of report 2022-01-06 · accession 0001562180-22-000336 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-07 | 2022-01-06 | PHR | Linetsky David | SVP, Life Sciences | M - OptEx | $5.32 | +30.9K | 164.7K | +23% | +$164.7K |
| DM | 2022-01-07 | 2022-01-06 | PHR | Linetsky David | SVP, Life Sciences | M - OptEx | $0.00 | -30.9K | 475 | -98% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-06 | M | A | 5,688 | $8.03 | 171,338 | D | — | — | (F1) A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2022-01-06 | M | A | 948 | $4.71 | 165,650 | D | — | — | (F1) A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 3 | Common | Common Stock | 2022-01-06 | M | A | 24,314 | $4.71 | 164,702 | D | — | — | (F1) A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 4 | Derivative | Stock Options (Right to buy) | 2022-01-06 | M | D | 5,688 | $0.00 | 5,689 | D | $8.03 · — to 2029-01-16 | 5,688 Common Stock | (F4) 25% of this option vested and became exercisable on January 17, 2020, with the remainder vesting in three (3) equal annual installments thereafter. |
| 5 | Derivative | Stock Options (Right to buy) | 2022-01-06 | M | D | 24,314 | $0.00 | 5,689 | D | $4.71 · — to 2028-08-06 | 24,314 Common Stock | (F2) 25% of this option vested and became exercisable on August 7, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. |
| 6 | Derivative | Stock Options (Right to buy) | 2022-01-06 | M | D | 948 | $0.00 | 475 | D | $4.71 · — to 2028-01-30 | 948 Common Stock | (F3) 25% of this option vested and became exercisable on January 31, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. |